Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Syros Pharmaceuticals
480 Arsenal Street, Suite 130
Watertown, MA 2472
Phone: 617-744-1340
www.syros.com

Syros Pharmaceuticals is a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros' proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics. Syros' initial focus is in cancer, but the company platform will also be applicable to other therapeutic areas.

Key Contact
Name
Nancy Simonian, M.D.
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
04/11/13 $30,000,000 Series A ARCH Venture Partners
Flagship Ventures
undisclosed
10/27/14 $53,000,000 Series B Aisling Capital
Alexandria Real Estate Equities
ARCH Venture Partners
Flagship Ventures
Polaris Partners
Redmile Group
WuXi Corporate Venture Fund
undisclosed
01/13/16 $40,000,000 Aisling Capital
Alexandria Real Estate Equities
Casdin Capital
Deerfield Management Company, L.P.
Fidelity Investments
Polaris Partners
Redmile Group
WuXi Corporate Venture Fund
undisclosed


Featured Reading